Leadership
Director
David J. Schneider, MD, FACC, FAHA - Director
In August, 2013,David Schneider, MD, was named to succeed Burton E. Sobel, MD, as Director ofCVRI-VT. Dr. Schneider is a Professor of Medicine at The University ofVermont andDirector of Cardiovascular Services for The University ofVermont Health Network.
Following medical school at the University of Cincinnati andresidency at the University of Colorado, where he served as Chief MedicalResident, Dr. Schneider completed his fellowship at Washington University, St.Louis under Dr. Sobel.
Dr. Schneider has won awards as both a student and aphysician/scientist (including UVM’s 2013 Department of Medicine ResearchMentor Award for mentorship of a fellow or resident) and has been named teacherof the year four times. He has an active research program focused on causalconnections between diabetes and heart disease, and the role of platelets inthe development and progression of atherosclerosis.Dr. Schneider holds several patents includingthe use of a novel biomarker, FcɣRIIa, asa precision tool to guide care of patients with atherosclerotic vasculardisease
He is active in national and international professional societies,is a member of the editorial board of the American Journal of Cardiology, andhas published more than 150 manuscripts, authored numerous chapters, and edited abook titled Diabetes and Heart Disease.
Bio •E-mail
Board of Directors
Governing oversight of CVRI-VT is providedby a Board of Directors, comprised of the Director,five members broadly representative of he diverse areas of ongoing cardiovascular research in the College and University, and a representative appointed by the Dean's Office. All members may vote on all proposalsand approval is by a simple majority.In addition to the Director, the current Board of Directors includes:
Ira Bernstein, MD
John Van Sicklen Maeck Professor and Chair
Department of Obstetrics, Gynecology & Reproductive Sciences and a former Senior Associate Deanfor Research in the College of Medicine
2016-2017 UVMUniversity Scholar
Areas of Expertise: Fetal growth, fetal growth abnormalities, pre-eclampsia, maternal physiology
Marilyn J. Cipolla, PhD, FAHA
Chair, Electrical & Biomedical Engineering
Professor, Department of Neurological Sciences
Joint appointments in Pharmacology and in Obstetrics, Gynecology & Reproductive Sciences
2015-2016 UVMUniversity Scholar
2020 Medical Alumni Association Distinguished Graduate Alumni Award
Areas of Expertise: Acute ischemic stroke, vascular mechanisms of stroke injury, cerebrovascular adaptation to pregnancy and pre-eclampsia, seizure-induced brain injury in pre-eclampsia
.tmb-thumb200.jpg?sfvrsn=c34a57f1_1 "Leadership - Cardiovascular Research Institute | College of Medicine (4)")
Mary Cushman, MD, MSc, FAHA
Professor and Vice Chair for Emerging Researchers, Department of Medicine
Co-Director, Vermont Center on Cardiovascular and Brain Health Larner College of Medicine, University of Vermont
Director, Thrombosis and Hemostasis Program, University of Vermont Medical Center
2019-2020 UVMUniversity Scholar
Editor-in-Chief ofResearch and Practice in Thrombosis & Haemostasis
Areas of Expertise: Treatment of venous thrombosis and related disorders; research on etiology of cardiovascular diseases and stroke through studies of biomarkers in epidemiologic studies
Bio•E-mail
Chris Holmes, MD, PhD, FACP
Professor, Department of Medicine
Deputy Division Chief, Hematology/Oncology
Assistant Director, Thrombosis and Hemostasis Program, University of Vermont Medical Center
Areas of Expertise: Role of platelets in tumor angiogenesis and metastasis and the inhibition of cancer progression using platelet antagonist therapy; thrombosis and hemostasis.
Bio•E-mail
Mark T. Nelson, PhD, FAHA
Chair, Department of Pharmacology and University Distinguished Professor
Joint appointments in Molecular Physiology and Biophysics and Surgery
2019 member, National Academy of Sciences
1996-1997 UVM University Scholar
Visiting Professor, University of Oxford, UK; Professor, Institute of Cardiovascular Science, University of Manchester, UK
Areas of Expertise: Cardiovascular pharmacology, calcium signaling
David M. Warshaw, PhD, FAHA
Professor and Chair
Department of Molecular Physiology & Biophysics
1999-2000 UVMUniversity Scholar
2021 University Distinguished Professor
Areas of Expertise: Cardiac muscle contractile protein function in normal and disease states
Former Board of Directors
Harold L. Dauerman, MD
Professor of Medicine and Surgery
Network Director, Interventional Cardiology
UVM Health Network
Executive Editor, Journal of the American College of Cardiology, Editor in Chief,Coronary Artery Disease(2013-2018), Editorial Board memberCirculation: Cardiovascular Interventions
Areas of Expertise: Coronary and structural heart interventions (aortic and mitral valve therapies), ischemic heart disease, intracoronary imaging, regional networks for acute myocardial infarction
Bio•E-mail
